Home > News > Starpharma: A “Nano” Star on the Rise
March 17th, 2005
Starpharma: A “Nano” Star on the Rise
Abstract:
On Monday, Starpharma—an Australian-based biopharmaceutical company focused on the development and application of dendrimer-based nanotechnologies—announced it was launching a new company, Dimerix Bioscience, to develop technology for the new field of receptor coupling. The overall size of the deal is pretty small—about AUD$200,000—and Starpharma will only have a 30% equity stake in the company, but it is yet another indication of Starpharma’s growing sophistication in leveraging its impressive intellectual property position in the area of dendrimer-based nanotechnologies.
Source:
NanoNovus
Bookmark:
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
Multiphoton polymerization: A promising technology for precision medicine February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
SMART researchers pioneer first-of-its-kind nanosensor for real-time iron detection in plants February 28th, 2025
Profiles
Russia’s Nano-enabled Products Market to Witness Massive Growth February 8th, 2011
Adept Technology Announces Orders for Over $600K from Chinese Partner January 18th, 2011
Nanostart-held ItN Nanovation Receives Major Follow-on Order in Saudi Arabia November 29th, 2010
Homegrown Companies Developing Batteries for Clean Energy Storage November 2nd, 2010
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||